In adults, several studies have evaluated the usefulness of copeptin in the diagnostic pathways of AVP-related diseases, as well as its potential role as prognostic marker in some clinical conditions such as acute myocardial lesions, renal and heart failure, stroke, and sepsis [7, 9, 30–41, 43–47]. This evidence concerns the gene AVP and Sepsis.